---

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

---

 

Form 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

---

 

October 29, 2003 (Date of earliest event reported)

 

---

 

 

BIOLASE TECHNOLOGY, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

 

Delaware		000-19627		87-0442441
(State or Other Jurisdiction of Incorporation or Organization)		(Commission file number)		(I.R.S. Employer Identification No.)

 

981 Calle Amanecer

San Clemente, California 92673

(Address of Principal Executive Offices, Including Zip Code)

 

(949) 361-1200

(Registrant’s Telephone Number, Including Area Code)

 

 

---

---

Item 7.    Financial Statements and Exhibits.

 

(c) Exhibits.

 

99.1		Press Release, dated October 29, 2003, announcing third quarter 2003 results.

 

Item 12.    Results of Operations and Financial Condition.

 

On October 29, 2003, BioLase Technology, Inc. issued a press release announcing its financial results for the quarter ended September 30, 2003. A copy of the earnings release is furnished herewith as Exhibit 99.1.

 

2

---

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated: October 30, 2003						BIOLASE TECHNOLOGY, INC., (Registrant)
						By:		/s/ EDSON J. ROOD
								Edson J. Rood Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)

 

3